Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NYXH

Nyxoah SA

Dec 12 • 10:39AM ET

7.93

Dollar change -0.03
Percentage change -0.34	%

Healthcare • Medical Instruments & Supplies • Belgium • NASD

Peers: INSP PODD TNDM IART NVRO ZBH GMED SENS SGHT BFLY

| Held by: DFIC BMED DFIS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.86	Insider Own	57.53%	Shs Outstand	34.39M	Perf Week	5.35%
Market Cap	272.57M	Forward P/E	-	EPS next Y	-1.89	Insider Trans	0.00%	Shs Float	14.59M	Perf Month	-9.85%
Income	-57.50M	PEG	-	EPS next Q	-0.50	Inst Own	16.99%	Short Float	0.49%	Perf Quarter	1.16%
Sales	5.51M	P/S	49.47	EPS this Y	-11.21%	Inst Trans	124.74%	Short Ratio	1.00	Perf Half Y	-1.21%
Book/sh	3.40	P/B	2.33	EPS next Y	-1.01%	ROA	-38.10%	Short Interest	0.07M	Perf Year	69.87%
Cash/sh	2.31	P/C	3.44	EPS next 5Y	-	ROE	-49.39%	52W Range	4.00 - 20.00	Perf YTD	70.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-27.28%	ROI	-40.74%	52W High	-60.34%	Beta	1.41
Dividend TTM	-	Quick Ratio	4.95	Sales past 5Y	289.43%	Gross Margin	8.85%	52W Low	98.32%	ATR (14)	0.44
Dividend Ex-Date	-	Current Ratio	5.28	EPS Y/Y TTM	-3.87%	Oper. Margin	-1025.18%	RSI (14)	41.65	Volatility	6.79% 5.34%
Employees	-	Debt/Eq	0.22	Sales Y/Y TTM	35.22%	Profit Margin	-1044.10%	Recom	1.44	Target Price	15.78
Option/Short	No / Yes	LT Debt/Eq	0.21	EPS Q/Q	-88.65%	Payout	-	Rel Volume	0.62	Prev Close	7.96
Sales Surprise	-6.77%	EPS Surprise	-7.78%	Sales Q/Q	30.99%	Earnings	Nov 06 AMC	Avg Volume	71.31K	Price	7.93
SMA20	-1.31%	SMA50	-10.79%	SMA200	-17.30%	Trades		Volume	9,698	Change	-0.34%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-23	Initiated	H.C. Wainwright	Buy
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-21-22	Initiated	Oppenheimer	Outperform	$30
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$21
Dec-21-21	Resumed	Cantor Fitzgerald	Overweight	$47
Jul-28-21	Initiated	Cantor Fitzgerald	Overweight	$43

Nov-27-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-20-24 04:05PM	Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 01:00AM	Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 (GlobeNewswire)
Nov-18-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Nov-06-24 04:05PM	Nyxoah Reports Third Quarter Financial and Operating Results (GlobeNewswire)
04:45PM	Loading…
Nov-04-24 04:45PM	Nyxoah Appoints John Landry as Chief Financial Officer (GlobeNewswire) +5.40%
Oct-25-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-22-24 04:30PM	Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-15-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-09-24 04:35PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-08-24 05:49PM	Nyxoah Secures $27 Million to Boost U.S. Presence (TipRanks)
Oct-07-24 05:00PM	Nyxoah Raises $27 Million through its At-the-Market Offering (GlobeNewswire)
Sep-27-24 04:30PM	DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update (GlobeNewswire) +5.56%
02:05AM	Information on the total number of voting rights and shares (GlobeNewswire)
02:00AM	Loading…
02:00AM	Publication relating to transparency notifications (GlobeNewswire)
Sep-05-24 04:30PM	Nyxoah to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-02-24 04:05PM	Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device (GlobeNewswire)
Aug-06-24 04:05PM	Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results (GlobeNewswire)
Jul-29-24 04:30PM	Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 (GlobeNewswire)
Jul-15-24 02:00AM	Nyxoah Appoints Scott Holstine as Chief Commercial Officer (GlobeNewswire)
Jul-03-24 06:30AM	Nyxoah Has Signed a 37.5 Million Loan Facility Agreement with the European Investment Bank (GlobeNewswire) +5.27%
Jul-01-24 02:00AM	Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA (GlobeNewswire)
Jun-28-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Jun-03-24 04:30PM	Nyxoah to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -8.61%
04:15PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:05PM	Publication relating to transparency notifications (GlobeNewswire)
May-31-24 02:00AM	Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares (GlobeNewswire)
May-28-24 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
May-23-24 09:59AM	Nyxoah Announces Pricing of Offering (GlobeNewswire) -17.69%
04:10PM	Loading…
May-22-24 04:10PM	Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program (GlobeNewswire)
04:05PM	Nyxoah Announces Proposed Offering of Ordinary Shares (GlobeNewswire)
May-14-24 04:05PM	Nyxoah Reports First Quarter 2024 Financial and Operating Results (GlobeNewswire) +8.25% +7.20%
May-13-24 04:30PM	Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire) +7.53%
May-10-24 01:00AM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024 (GlobeNewswire)
Apr-30-24 01:31PM	ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript (Insider Monkey) -6.55%
Apr-11-24 04:30PM	Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer (GlobeNewswire) -10.41% -7.30%
Mar-29-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Mar-25-24 02:05AM	Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology Head & Neck Surgery Foundation (GlobeNewswire) -7.88%
Mar-19-24 04:05PM	Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints (GlobeNewswire) -14.21% -16.92%
Mar-07-24 09:45AM	Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.22%
Mar-05-24 09:52PM	NYXH Stock Earnings: Nyxoah Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -5.24% -8.33%
04:05PM	Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results (GlobeNewswire)
Feb-29-24 04:30PM	Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference (GlobeNewswire) +7.07%
Feb-15-24 04:30PM	Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024 (GlobeNewswire) +7.32%
Jan-17-24 04:05PM	Nyxoah Announces 2024 Strategic Priorities (GlobeNewswire) -6.04%
Jan-09-24 04:05PM	Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023 (GlobeNewswire)
Dec-11-23 01:30AM	Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio (GlobeNewswire)
Dec-08-23 04:30PM	Publication Relating to a Transparency Notification (GlobeNewswire)
Nov-28-23 04:30PM	Nyxoah Strengthens its Executive Leadership Team (GlobeNewswire)
Nov-27-23 08:19AM	Why Is Nyxoah (NYXH) Stock Up 4% Today? (InvestorPlace)
Nov-21-23 04:30PM	Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-08-23 04:05PM	Nyxoah Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire) -15.10%
Nov-07-23 04:30PM	Nyxoah to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-26-23 04:30PM	Nyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023 (GlobeNewswire)
Sep-28-23 04:30PM	Nyxoah Announces Partnership with ResMed in Germany (GlobeNewswire)
Sep-12-23 04:30PM	Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Sep-05-23 04:30PM	Nyxoah to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-30-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
Aug-08-23 04:05PM	Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results (GlobeNewswire)
Jul-27-23 04:30PM	Publication Relating to a Transparency Notification (GlobeNewswire)
04:30PM	Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023 (GlobeNewswire)
04:30PM	Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference (GlobeNewswire)
04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
May-16-23 04:05PM	Nyxoah Reports First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-12-23 01:00AM	Invitation to Attend the Annual Shareholders Meeting of the Company to be Held on June 14, 2023 (GlobeNewswire)
May-10-23 04:05PM	Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer (GlobeNewswire)
May-01-23 04:30PM	Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023 (GlobeNewswire) +7.79%
Apr-20-23 04:30PM	Publication Relating to Transparency Notifications (GlobeNewswire) +11.06%
Apr-17-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire) +10.01%
Apr-13-23 04:05PM	Nyxoah Raises $3 Million from its At-the-Market Equity Offering (GlobeNewswire) +10.19% +12.37%
Mar-31-23 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
Mar-27-23 04:05PM	Nyxoah Raises $3 Million from an At-the-Market Equity Offering (GlobeNewswire) +8.68%
Mar-23-23 04:05PM	Nyxoah Announces a $15 Million Private Placement Financing (GlobeNewswire)
Mar-22-23 04:05PM	Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-08-23 04:30PM	Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Mar-07-23 04:30PM	Nyxoah to Participate in the Oppenheimer 33rd Annual Healthcare Conference (GlobeNewswire)
Mar-06-23 01:30AM	Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones (GlobeNewswire)
Feb-22-23 06:00AM	Nyxoah Announces Inaugural Investor & Analyst Meeting (GlobeNewswire) +10.75%
Feb-21-23 04:30PM	Nyxoah Announces Inaugural Investor & Analyst Meeting (GlobeNewswire) -6.82%
Jan-09-23 04:30PM	Nyxoah Appoints Mr. Daniel Wildman to its Board of Directors (GlobeNewswire)
Dec-22-22 04:12PM	Nyxoah Files Shelf Registration Statement and Announces At-the-Market Equity Offering Program (GlobeNewswire)
Nov-17-22 04:30PM	Nyxoah to Participate in the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-16-22 09:55AM	Wall Street Analysts See a 240% Upside in Nyxoah SA (NYXH): Can the Stock Really Move This High? (Zacks)
Nov-08-22 04:05PM	Nyxoah Reports Third Quarter 2022 Financial and Operating Results (GlobeNewswire)
Oct-24-22 04:30PM	Nyxoah Announces Change to Board of Directors (GlobeNewswire)
Oct-20-22 04:30PM	Nyxoah to Participate in the Jefferies London Healthcare Conference (GlobeNewswire) -8.14% +7.65%
Oct-18-22 04:30PM	Nyxoah to Release Third Quarter Financial Results on November 8, 2022 (GlobeNewswire)
Sep-30-22 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Aug-18-22 04:30PM	Nyxoah to Participate in the 17th Annual Wells Fargo Securities Healthcare Conference (GlobeNewswire)
Aug-11-22 09:55AM	Wall Street Analysts Believe Nyxoah SA (NYXH) Could Rally 170%: Here's is How to Trade (Zacks)
Aug-08-22 11:00PM	Nyxoah S.A. (NYXH) Q2 2022 Earnings Call Transcript (Motley Fool)
04:05PM	Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results (GlobeNewswire)
Aug-04-22 10:25AM	CareCloud, Inc. (MTBC) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-02-22 02:00AM	Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test (GlobeNewswire)
Jul-27-22 04:30PM	Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire)
Jul-19-22 04:30PM	Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022 (GlobeNewswire) +12.22%
06:47AM	Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea (Benzinga)
Jul-18-22 04:30PM	Nyxoah Announces CE Mark Approval for Genio® 2.1 (GlobeNewswire)

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NYXH

Nyxoah SA

Upgrade your FINVIZ experience